TY  - JOUR
AU  - Jiménez Valero, Santiago
AU  - Moreno, Raúl
AU  - Sanchez Recalde, Ángel
AU  - Galeote, Guillermo
AU  - Calvo Martín, José Luis
AU  - Viana Tejedor, Ana Teresa
AU  - Lopez de Sá, Esteban
AU  - López Sendón, Jose
PY  - 2008
SN  - 1753-9447
SN  - 1753-9455
UR  - https://hdl.handle.net/20.500.14352/100823
T2  - Therapeutic Advances in Cardiovascular Disease
AB  - Restenosis is an important limitation of percutaneous coronary interventions (PCI). In-stent restenosis is mainly due to neointimal hyperplasia, a proliferative process modulated by inflammatory mechanisms. Numerous technical and pharmacological means...
LA  - eng
M2  - 137
PB  - Sage
TI  - Review: Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
TY  - journal article
VL  - 2
ER  -